SPEAKER
Univ.-Prof. Dr. rer. nat. Timo Strünker
Centre of Reproductive Medicine and Andrology (CeRA)

• Ros4/003/23 - Transcription factor PU.1-controlled stem cell genes in acute myeloid leukemia
  Principal investigator: Frank Rosenbauer
  Funding period: 01/2023 - 12/2025
• Rö4/006/23 - CAR T cells with antigen-induced secretion of a soluble IGF1R signaling inhibitor for combined molecular and immune targeting of Ewing sarcoma
  Principal investigators: Claudia Rössig, Sebastian Bäumer
  Funding period: 01/2023 - 12/2025

• Tüt4/011/23 - Contribution of the piRNA pathway to spermatogenic failure and male infertility
  Principal investigator: Frank Tüttelmann
  Funding period: 01/2023 - 12/2025
   
• Weh4/022/23 - Impact of osteocyte-cancer cell crosstalk on bone homeostasis in multiple myeloma
  Principal investigator: Corinna Wehmeyer
  Funding period: 01/2023 - 12/2025

• Kek4/016/22 - Identifying mechanisms of microglia- tumor cell interactions in the induction of chemotherapy resistance in retinoblastoma
  Principal investigator: Kornelius Kerl
  Funding period: 01/2022 - 12/2024
• Ebl4/009/21 - Pinpointing distinct rhodocytin suprastructures and novel CLEC-2 targeting toxins to curb podoplanin-mediated platelet assistance of hematogenous metastasis
  Principal Investigator: Johannes Eble
  Funding period: 01/21 - 12/23
• Lud4/013/21 - Exploiting synergistic anti-cancer efficacy by combining oncolytic viruses and CAR Tcells to target lung cancer
  Principal Investigator: Stephan Ludwig
  Funding period: 01/21 - 12/23
• Mik4/015/21 - Investigation of the role of the Armadillo repeat-containing X-linked Protein (ARMCX)family in normal hematopoiesis and acute myeloid leukemia
  Principal Investigator: Jan-Henrik Mikesch
  Funding period: 01/21 - 12/23
• Kr4/031/21 - Characterization of new substrates of the tumor suppressor LKB1 in thepathogenesis of cancer
  Principal Investigator: Michael Krahn
  Funding period: 01/21 - 12/23